deininger lab banner


Deininger/O'Hare Lab




Welcome to the Deininger/O'Hare Lab


The Deininger/O'Hare lab expertise is in the study of leukemia. The lab's research program focuses on the biology of myeloproliferative neoplasms and the development of molecularly targeted therapies. We are especially interested in understanding the molecular mechanisms of resistance to tyrosine kinase inhibitors such as imatinib, a drug used to treat chronic myeloid leukemia and some other types of cancer.

Now seeking post-doctoral scholar, click here to apply.

For more information about our lab, contact Tony Pomicter: or 801-587-4077